Antinociceptive activity of agaricoglycerides extracted from mycelium of Ling Zhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)

International Journal of Medicinal Mushrooms

Volumn 12, Issue 3, 2010, Pages 273-278

  Han, Chunchao ^a  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Agaricoglycerides; Antinociceptive activity; Ganoderma lucidum; Ling Zhi or Reishi mushroom; Medicinal mushrooms

Indexed keywords

AGARICOGLYCERIDE; FORMALDEHYDE; GANODERMA LUCIDUM EXTRACT; NEUROLYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GANODERMA LUCIDUM; HOT PLATE TEST; IN VITRO STUDY; MOUSE; MUSHROOM; MYCELIUM; NONHUMAN; REACTION TIME; THERMAL STIMULATION; WRITHING TEST;

ANIMALIA; BASIDIOMYCOTA; GANODERMA LUCIDUM; MUS;

EID: 78650137303     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v12.i3.60     Document Type: Article

References (26)

1. Mizuno T. Bioactive substances in Hericium erinaceus (Bull.:Fr.) Pers. (Yamabushitake), and its medicinal utilization. Int J Med Mushr. 1999;1:105-9.
2. Lindequist U, Lesnau A, Teuscher E, Pilgrim H. Untersuchungen zur antiviralen Wirksamkeit von Ergosterolperoxid. Pharmazie. 1989;44:579-80. [in German]
3. Saito T, Aoki F, Hirai H, Inagaki T, Matsunaga Y, Sakakibara T, Sakemi S, Suzuki Y, Watanabe S, Suga O, Sujaku T, Smogowicz AA, Truesdell SJ, Wong JW, Nagahisa A, Kojima Y, Kojima N. Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. J Antibiot. 1998;51:983-90. (Pubitemid 28554166)
4. Stadler M, Hellwig V, Mayer-Bartschmid A, Denzer D, Wiese B, Burkhardt N. Novel analgesic triglycerides from cultures of Agaricus macrosporus and other Basidiomycetes as selective inhibitors of neurolysin. J Antibiot (Tokyo). 2005;58:775-86. (Pubitemid 43151683)
5. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int J Med Mushr. 1999;1:31-62.
6. Mahajna J, Dotan N, Zaidman BZ, Petrova RD, Wasser SP. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutr Cancer. 2009;61:16-26.
7. Kabir Y, Kimura S, Tamura T. Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol (Tokyo). 1988;34:433-8.
8. Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009;10:717-42.
9. Hijikata Y, Yamada S. Effect of Ganoderma lucidum on postherpetic neuralgia. Am J Chin Med. 1998;26:375-81. (Pubitemid 128730961)
10. Koyama K, Imaizumi T, Akiba M. Antinociceptive components of Ganoderma lucidum. Planta Med. 1997;63:224-7.
11. Han C, Yuan J, Wang Y. Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol. 2006;20:191-6. (Pubitemid 44311020)
12. Han C, Cui B, Wang Y. Vanadium uptake by biomass of Coprinus comatus and their effect on hyperglycemic mice. Biol Trace Elem Res. 2008;124:35-9.
13. Koster R, Anderson M, DeBeer EJ. Acetic acid for analgesic screening. Fed Proc. 1959;18:418-20.
14. Fasmer OB, Berge OG, Hole K. Changes in nociception after lesions of descending serotonergic pathways induced with 5,6-dihydroxytryptamine. Different effects in the formalin and tail-flick tests. Neuropharmacol. 1985;24:729-34.
15. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 1987;30:103-14. (Pubitemid 17094194)
16. Woolfe G, MacDonald AD. The evaluation of the analgesic action of pethidine hydrochloride (demerol). J Pharmacol Exp Ther. 1944;80:300-7.
17. Duncan DB. Multiple range tests for correlated and heteroscedastic means. Biometrics. 1957;13:164-76.
18. Shrimpton CN, Smith AI. Soluble neutral metalloproteases: Physiological regulators of peptide action. J Peptide Sci. 2000;6:251-63.
19. Tyler BM, Cusack B, Douglas CL, Souder T, Richelson E. Evidence for additional neurotensin receptor subtypes: neurotensin analogues that distinguish between neurotensinmediated hypothermia and antinociception. Brain Res. 1998;792:246-52. (Pubitemid 28267537)
20. Dauch P, Vincent JP, Checler F. Specific inhibition of endopeptidase 24.16 by dipeptides. Eur J Biochem. 1991;202:269-76. (Pubitemid 20313288)
21. Vincent B, Dive V, Yiotakis A, Smadja C, Maldonado R, Vincent JP, Checler F. Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3. 4. 24. 15 and 3. 4. 24. 16: effect on neurotensin degradation in vitro and in vivo. Brit J Pharmacol. 1995;115:1053-63.
22. Jirácek J, Yiotakis A, Vincent B, Checler F, Dive V. Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a schematic approach based on combinatorial chemistry of phosphinic peptides. J Biol Chem, 1996;271:19608-11. (Pubitemid 26271640)
23. Collier HOJ, Dinneen JC, Johnson CA, Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother. 1968;32:295-310.
24. Deraedt R, Jouquey S, Delevallée F, Flahaut M. Release of prostaglandins-E and prostaglandins-F in an algogenic reaction and its inhibition. Eur J Pharmacol. 1980;61:17-24. (Pubitemid 10178021)
25. Hosseinzadeh H, Ramezani M, Salmani GA. Antinociceptive, anti-inflammatory and acute toxicity effect of Zataria multiflora Boiss extracts in mice and rats. J Ethnopharmacol. 2000;73:379-85.
26. Beirith A, Santos AR, Rodrigues AL, Creczynski-Pasa TB, Calixto JB. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur J Pharmacol. 1998;345:233-45. (Pubitemid 28179563)